$GBLX
GB SCIENCES INC

2023 Q3 Form 10-K Financial Statement

#000143774923019964 Filed on July 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q1 2023
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $551.5K $529.6K $1.672M
YoY Change 99.93% 17.43% -10.51%
% of Gross Profit
Research & Development $490.3K
YoY Change -40.3%
% of Gross Profit
Depreciation & Amortization $620.00 $0.00 $61.66K
YoY Change -96.96% -100.0% 139.22%
% of Gross Profit
Operating Expenses $551.5K $529.6K $1.672M
YoY Change 99.93% 17.43% 103.61%
Operating Profit -$551.5K -$529.6K -$1.672M
YoY Change 99.93% 17.43% -10.51%
Interest Expense $42.74K -$61.39K -$178.7K
YoY Change 14.84% -60.34% -137.63%
% of Operating Profit
Other Income/Expense, Net $117.3K $100.0K $100.0K
YoY Change -415.06% 539.39% -94.19%
Pretax Income -$434.2K -$2.865M -$4.125M
YoY Change 38.71% -20.59% 2715.29%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$434.2K -$2.865M -$4.125M
YoY Change 38.71% -21.89% 677.06%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding 381.9M 379.2M 357.7M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $104.5K $109.9K $109.9K
YoY Change -84.11% -53.01% -53.01%
Cash & Equivalents $104.5K $109.9K $109.9K
Short-Term Investments
Other Short-Term Assets $129.7K $199.6K $199.6K
YoY Change -41.26% 112.49% 112.49%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $234.2K $309.5K $309.5K
YoY Change -73.34% -5.59% -5.59%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $42.82K $42.82K
YoY Change -100.0% -98.07% -98.07%
TOTAL ASSETS
Total Short-Term Assets $234.2K $309.5K $309.5K
Total Long-Term Assets $0.00 $42.82K $42.82K
Total Assets $234.2K $352.3K $352.3K
YoY Change -92.49% -86.18% -86.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.992M $1.983M $1.983M
YoY Change 25.92% 19.66% 19.66%
Accrued Expenses $75.63K $422.4K $422.4K
YoY Change 343.02% 4287.97% 7.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.427M $1.396M $1.396M
YoY Change 21.94% 41.37% 41.37%
Total Short-Term Liabilities $4.852M $4.760M $4.760M
YoY Change 18.6% 20.94% 20.94%
LONG-TERM LIABILITIES
Long-Term Debt $75.00K $0.00 $0.00
YoY Change -65.85% -100.0% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $75.00K $0.00 $0.00
YoY Change -65.85% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.852M $4.760M $4.760M
Total Long-Term Liabilities $75.00K $0.00 $0.00
Total Liabilities $4.927M $4.760M $4.760M
YoY Change 14.3% 9.85% 9.85%
SHAREHOLDERS EQUITY
Retained Earnings -$109.4M -$108.7M
YoY Change 3.82% 3.94%
Common Stock $40.39K $38.19K
YoY Change 6.79% 17.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.693M -$4.407M -$4.407M
YoY Change
Total Liabilities & Shareholders Equity $234.2K $352.3K $352.3K
YoY Change -92.49% -86.18% -86.18%

Cashflow Statement

Concept 2023 Q3 2023 Q1 2023
OPERATING ACTIVITIES
Net Income -$434.2K -$2.865M -$4.125M
YoY Change 38.71% -21.89% 677.06%
Depreciation, Depletion And Amortization $620.00 $0.00 $61.66K
YoY Change -96.96% -100.0% 139.22%
Cash From Operating Activities -$407.8K -$219.9K -$1.527M
YoY Change -33.74% -66.95% -18.18%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $31.65K
YoY Change -100.0% -100.0% -115.83%
Acquisitions
YoY Change
Other Investing Activities $235.0K $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $235.0K $0.00 -$31.65K
YoY Change -875.07% -100.0% -102.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.483M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 247.4K 55.76K 1.435M
YoY Change -80.2% -111.04% -389.26%
NET CHANGE
Cash From Operating Activities -407.8K -219.9K -1.527M
Cash From Investing Activities 235.0K 0.000 -31.65K
Cash From Financing Activities 247.4K 55.76K 1.435M
Net Change In Cash 74.61K -164.1K -124.0K
YoY Change -87.64% -87.08% -86.4%
FREE CASH FLOW
Cash From Operating Activities -$407.8K -$219.9K -$1.527M
Capital Expenditures $0.00 $0.00 $31.65K
Free Cash Flow -$407.8K -$219.9K -$1.559M
YoY Change -30.31% -61.1% -6.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2390297 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
104201 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
41230 usd
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
1765 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
0 usd
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
99489 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
381872561
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
381872561
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
325037557
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
325037557
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2021 gblx Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
9697146
CY2022 gblx Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
3116550
CY2023 gblx Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
-0
CY2023 gblx Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
9201000
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-55462
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-3733133
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
9205 W. Russell Road, Suite 240
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89148
CY2023 dei City Area Code
CityAreaCode
866
CY2023 dei Local Phone Number
LocalPhoneNumber
721-0297
CY2023 dei Security12g Title
Security12gTitle
Common Stock $.0001 Par Value
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
11300000 usd
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
381872561
CY2023 dei Auditor Firm
AuditorFirmId
5036
CY2023 dei Auditor Location
AuditorLocation
Margate, Florida
CY2023 dei Auditor Name
AuditorName
ASSURANCE DIMENSIONS
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109912 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
233893 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
199592 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
93933 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
309504 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
327826 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
42819 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2222074 usd
CY2023Q1 us-gaap Assets
Assets
352323 usd
CY2022Q1 us-gaap Assets
Assets
2549900 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
346806 usd
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
384769 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75628 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9627 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1396077 usd
CY2022Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
987565 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
958455 usd
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
896495 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4759706 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3935464 usd
CY2023Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2022Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
397308 usd
CY2023Q1 us-gaap Liabilities
Liabilities
4759706 usd
CY2022Q1 us-gaap Liabilities
Liabilities
4332772 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
38187 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
32504 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104259745 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
102764746 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-108705315 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104580122 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4407383 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1782872 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
352323 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2549900 usd
CY2023 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023 us-gaap Gross Profit
GrossProfit
0 usd
CY2022 us-gaap Gross Profit
GrossProfit
0 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1672281 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1868734 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1672281 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1868734 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
22405 usd
CY2023 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 usd
CY2022 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
5206208 usd
CY2023 us-gaap Interest Expense
InterestExpense
178652 usd
CY2022 us-gaap Interest Expense
InterestExpense
474768 usd
CY2023 gblx Gain Loss On Modification Of Notes Receivable
GainLossOnModificationOfNotesReceivable
0 usd
CY2022 gblx Gain Loss On Modification Of Notes Receivable
GainLossOnModificationOfNotesReceivable
-3025000 usd
CY2023 gblx Gain Loss On Impairment Of Capitalized Patent Costs
GainLossOnImpairmentOfCapitalizedPatentCosts
-2374261 usd
CY2022 gblx Gain Loss On Impairment Of Capitalized Patent Costs
GainLossOnImpairmentOfCapitalizedPatentCosts
0 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-15639 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
100000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2452913 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1722206 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4125194 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-146528 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4125194 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-146528 usd
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-384345 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-4125194 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-530873 usd
CY2023 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-4125194 usd
CY2022 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-146528 usd
CY2023 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
0 usd
CY2022 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-384345 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4125194 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-530873 usd
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.00
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.00
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
357721189
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
317621942
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1473928 usd
CY2022 gblx Exercise Of Warrants For Stock Value
ExerciseOfWarrantsForStockValue
56394 usd
CY2022 gblx Induced Dividend From Warrant Exercises
InducedDividendFromWarrantExercises
0 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
60667 usd
CY2022 gblx Stock Options Issued For Services
StockOptionsIssuedForServices
28800 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-530873 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1782872 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17333 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1483350 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-4125194 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4407383 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-4125194 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-530873 usd
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-384345 usd
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4125194 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-146528 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
61660 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
70488 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
17333 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
60667 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
60024 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
356340 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
22405 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-15639 usd
CY2023 gblx Gain Loss On Modification Of Notes Receivable
GainLossOnModificationOfNotesReceivable
-0 usd
CY2022 gblx Gain Loss On Modification Of Notes Receivable
GainLossOnModificationOfNotesReceivable
-3025000 usd
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2374261 usd
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-0 usd
CY2022 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
5206208 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
105659 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-162318 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-20195 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
821253 usd
CY2023 gblx Increase Decrease In Accrued Liabilities Excluding Interest Payable
IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable
66001 usd
CY2022 gblx Increase Decrease In Accrued Liabilities Excluding Interest Payable
IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable
-948319 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-37963 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
118286 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
61960 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
120911 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-84913 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1526861 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1778382 usd
CY2023 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 usd
CY2022 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-87772 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1526861 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1866154 usd
CY2023 us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
0 usd
CY2022 us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
1648772 usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
31650 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
200000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-31650 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1448772 usd
CY2023 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0 usd
CY2022 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
1567 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31650 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1450339 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
138728 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
50000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1483350 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
48820 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
575000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1434530 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-392538 usd
CY2023 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0 usd
CY2022 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-103387 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1434530 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-495925 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-123981 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-911740 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
233893 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1145633 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
109912 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
233893 usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
-0 usd
CY2022Q1 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
-0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109912 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
233893 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023 gblx Noncash Additions For Capitalized Patent Costs
NoncashAdditionsForCapitalizedPatentCosts
246132 usd
CY2022 gblx Noncash Additions For Capitalized Patent Costs
NoncashAdditionsForCapitalizedPatentCosts
0 usd
CY2023 gblx Notes Receivable Issued
NotesReceivableIssued
0 usd
CY2022 gblx Notes Receivable Issued
NotesReceivableIssued
3025000 usd
CY2023 us-gaap Notes Reduction
NotesReduction
0 usd
CY2022 us-gaap Notes Reduction
NotesReduction
2612854 usd
CY2023 gblx Accrued Management Fees Payables Reduction
AccruedManagementFeesPayablesReduction
0 usd
CY2022 gblx Accrued Management Fees Payables Reduction
AccruedManagementFeesPayablesReduction
850000 usd
CY2023 gblx Depreciation Capitalized In Inventory
DepreciationCapitalizedInInventory
0 usd
CY2022 gblx Depreciation Capitalized In Inventory
DepreciationCapitalizedInInventory
349015 usd
CY2023 gblx Patent Filing And Drafting Costs Capitalized In Intangible Assets
PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets
0 usd
CY2022 gblx Patent Filing And Drafting Costs Capitalized In Intangible Assets
PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets
347617 usd
CY2023 gblx Stock Options Issued For Services
StockOptionsIssuedForServices
0 usd
CY2022 gblx Stock Options Issued For Services
StockOptionsIssuedForServices
28800 usd
CY2023 gblx Induced Dividend From Exercise Of Warrants
InducedDividendFromExerciseOfWarrants
0 usd
CY2022 gblx Induced Dividend From Exercise Of Warrants
InducedDividendFromExerciseOfWarrants
163017 usd
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-108705315 usd
CY2023Q1 gblx Working Capital Deficit
WorkingCapitalDeficit
-4450202 usd
CY2022Q1 gblx Working Capital Deficit
WorkingCapitalDeficit
-3607638 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1526861 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1866154 usd
CY2022 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-87772 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowances for doubtful accounts, collectability of notes receivable, inventory valuation and standard cost allocations, valuation of initial right-of-use assets and corresponding lease liabilities, valuation of beneficial conversion features in convertible debt, valuation of the assets and liabilities of discontinued operations, stock-based compensation expense, purchased intangible asset valuations, deferred income tax asset valuation allowances, uncertain tax positions, litigation, other loss contingencies, and impairment of long lived assets.  These estimates and assumptions are based on current facts, historical experience and various other factors that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of costs and expenses that are <em style="font: inherit;">not</em> readily apparent from other sources. The actual results the Company experiences <em style="font: inherit;"> may </em>differ materially and adversely from these estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b></b></p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"></p>
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
490291 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
821321 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
167252135
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
118594624
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.018 pure
CY2023 us-gaap Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items
IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
61960 usd
CY2023 gblx Income Tax Reconciliation Prior Year Tax Penalties
IncomeTaxReconciliationPriorYearTaxPenalties
41313 usd
CY2023 gblx Income Tax Reconciliation Accrued Interest On Prior Year Tax Liabilities
IncomeTaxReconciliationAccruedInterestOnPriorYearTaxLiabilities
20647 usd
CY2018 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
506145 usd
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
178727 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
958455 usd
CY2023 gblx Income Tax Reconciliation Cumulative Accrued Penalties And Interest
IncomeTaxReconciliationCumulativeAccruedPenaltiesAndInterest
273594 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
51260036 usd
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
52067273 usd
CY2023Q1 gblx Operating Loss Carryforwards Subject To Expiration
OperatingLossCarryforwardsSubjectToExpiration
34481122 usd
CY2022Q1 gblx Operating Loss Carryforwards Not Subject To Expiration
OperatingLossCarryforwardsNotSubjectToExpiration
17026440 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-182405 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
691042 usd
CY2023 gblx Effective Income Tax Rate Reconciliation Irc Section280e Amount
EffectiveIncomeTaxRateReconciliationIrcSection280eAmount
0 usd
CY2022 gblx Effective Income Tax Rate Reconciliation Irc Section280e Amount
EffectiveIncomeTaxRateReconciliationIrcSection280eAmount
132063 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
9246 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
5526 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-756430 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
579861 usd
CY2023 gblx Effective Income Tax Rate Reconciliation Adjustments To Valuation Of Deferred Tax Assets
EffectiveIncomeTaxRateReconciliationAdjustmentsToValuationOfDeferredTaxAssets
929589 usd
CY2022 gblx Effective Income Tax Rate Reconciliation Adjustments To Valuation Of Deferred Tax Assets
EffectiveIncomeTaxRateReconciliationAdjustmentsToValuationOfDeferredTaxAssets
-1408492 usd
CY2023 gblx Effective Income Tax Rate Reconciliation Tax Return Trueup
EffectiveIncomeTaxRateReconciliationTaxReturnTrueup
0 usd
CY2022 gblx Effective Income Tax Rate Reconciliation Tax Return Trueup
EffectiveIncomeTaxRateReconciliationTaxReturnTrueup
58277 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
58277 usd
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
61960 usd
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
76709 usd
CY2023 us-gaap Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items
IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
61960 usd
CY2022 us-gaap Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items
IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
134986 usd
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3147724 usd
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3144084 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10934127 usd
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10816588 usd
CY2023Q1 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
635250 usd
CY2022Q1 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
0 usd
CY2023Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1369 usd
CY2022Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1369 usd
CY2023Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
209714 usd
CY2022Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
209714 usd
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
14506018 usd
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
13749589 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14506018 usd
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13749589 usd
CY2023Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
221650 usd
CY2021Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
85843036
CY2022 gblx Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
2095333
CY2022 gblx Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
75124673
CY2023 gblx Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
56835004
CY2023 gblx Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
122758677
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17333 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
60667 usd
CY2023 gblx Class Of Warrant Or Right Expense
ClassOfWarrantOrRightExpense
17333 usd
CY2022 gblx Class Of Warrant Or Right Expense
ClassOfWarrantOrRightExpense
60667 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
17733334
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.11
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
17733334
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.11
CY2021 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
5206208 usd

Files In Submission

Name View Source Status
0001437749-23-019964-index-headers.html Edgar Link pending
0001437749-23-019964-index.html Edgar Link pending
0001437749-23-019964.txt Edgar Link pending
0001437749-23-019964-xbrl.zip Edgar Link pending
adsig.jpg Edgar Link pending
ex_487881.htm Edgar Link pending
ex_487882.htm Edgar Link pending
ex_487883.htm Edgar Link pending
ex_487884.htm Edgar Link pending
ex_487885.htm Edgar Link pending
ex_541952.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gblx-20230331.xsd Edgar Link pending
gblx20230331_10k.htm Edgar Link pending
gbsciences01.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pic1.jpg Edgar Link pending
gblx-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
gblx-20230331_def.xml Edgar Link unprocessable
gblx-20230331_lab.xml Edgar Link unprocessable
gblx-20230331_pre.xml Edgar Link unprocessable
gblx20230331_10k_htm.xml Edgar Link completed
pic2.jpg Edgar Link pending
pic3.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending